IBS-C Study A2306
| ISRCTN | ISRCTN47368803 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN47368803 |
| Secondary identifying numbers | CHTF919A2306 |
- Submission date
- 12/08/2003
- Registration date
- 11/09/2003
- Last edited
- 20/02/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Ms Marisa Carmen
Scientific
Scientific
Novartis Pharmaceuticals
One Health Plaza
East Hanover
07936
United States of America
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Not Specified |
| Scientific title | |
| Study objectives | Not provided at time of registration. |
| Ethics approval(s) | Not provided at time of registration. |
| Health condition(s) or problem(s) studied | Irritable bowel syndrome (IBS) with constipation |
| Intervention | Not provided at time of registration. |
| Intervention type | Other |
| Primary outcome measure | Not provided at time of registration. |
| Secondary outcome measures | Not provided at time of registration. |
| Overall study start date | 01/04/2002 |
| Completion date | 30/04/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Female |
| Target number of participants | THIS STUDY HAS COMPLETED PATIENT ENROLMENT |
| Key inclusion criteria | Females, 18 to 65 years, with IBS-C (Irritable Bowel Syndrome with constipation) |
| Key exclusion criteria | Not provided at time of registration. |
| Date of first enrolment | 01/04/2002 |
| Date of final enrolment | 30/04/2003 |
Locations
Countries of recruitment
- United States of America
Study participating centre
Novartis Pharmaceuticals
East Hanover
07936
United States of America
07936
United States of America
Sponsor information
Novartis Pharmaceuticals Corporation
Not defined
Not defined
One Health Plaza
East Hanover
07936
United States of America
"ROR" |
https://ror.org/028fhxy95 |
|---|
Funders
Funder type
Industry
Sponsored by Novartis Pharmaceuticals Corporation (http://click.atdmt.com/GTO/go/thbmbnov00700895gto/direct/01/)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
